TWI859182B - Peptide, method and composition for melanin polymerization and hair darkening - Google Patents
Peptide, method and composition for melanin polymerization and hair darkening Download PDFInfo
- Publication number
- TWI859182B TWI859182B TW109101268A TW109101268A TWI859182B TW I859182 B TWI859182 B TW I859182B TW 109101268 A TW109101268 A TW 109101268A TW 109101268 A TW109101268 A TW 109101268A TW I859182 B TWI859182 B TW I859182B
- Authority
- TW
- Taiwan
- Prior art keywords
- peptide
- composition
- melanin
- seq
- polymerization
- Prior art date
Links
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 title claims abstract description 74
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 67
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 238000006116 polymerization reaction Methods 0.000 title claims abstract description 23
- 210000004209 hair Anatomy 0.000 title claims abstract description 9
- 238000000034 method Methods 0.000 title abstract description 10
- 230000037308 hair color Effects 0.000 claims description 18
- 238000002360 preparation method Methods 0.000 claims description 11
- 230000000699 topical effect Effects 0.000 claims description 11
- 150000001413 amino acids Chemical class 0.000 claims description 9
- 239000002453 shampoo Substances 0.000 claims description 7
- 230000004936 stimulating effect Effects 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- 239000006071 cream Substances 0.000 claims description 4
- 239000002674 ointment Substances 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 239000000443 aerosol Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims 1
- 241000124008 Mammalia Species 0.000 abstract description 3
- 235000001014 amino acid Nutrition 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- -1 eumelanin Chemical compound 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000004264 Petrolatum Substances 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 239000008365 aqueous carrier Substances 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 229940066842 petrolatum Drugs 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- ICLYJLBTOGPLMC-KVVVOXFISA-N (z)-octadec-9-enoate;tris(2-hydroxyethyl)azanium Chemical compound OCCN(CCO)CCO.CCCCCCCC\C=C/CCCCCCCC(O)=O ICLYJLBTOGPLMC-KVVVOXFISA-N 0.000 description 1
- AXTGDCSMTYGJND-UHFFFAOYSA-N 1-dodecylazepan-2-one Chemical compound CCCCCCCCCCCCN1CCCCCC1=O AXTGDCSMTYGJND-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- QUOGESRFPZDMMT-UHFFFAOYSA-N L-Homoarginine Natural products OC(=O)C(N)CCCCNC(N)=N QUOGESRFPZDMMT-UHFFFAOYSA-N 0.000 description 1
- ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 1
- QUOGESRFPZDMMT-YFKPBYRVSA-N L-homoarginine Chemical compound OC(=O)[C@@H](N)CCCCNC(N)=N QUOGESRFPZDMMT-YFKPBYRVSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 108010067902 Peptide Library Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 description 1
- 235000008206 alpha-amino acids Nutrition 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229960002713 calcium chloride Drugs 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001508 eye Anatomy 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000003648 hair appearance Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 230000037048 polymerization activity Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229960002816 potassium chloride Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229960004249 sodium acetate Drugs 0.000 description 1
- 229960002668 sodium chloride Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 229940117013 triethanolamine oleate Drugs 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
Abstract
Description
本發明涉及一種用於哺乳動物中黑色素聚合及髮色變黑的胜肽,及其方法與組合物。The present invention relates to a peptide for melanin polymerization and hair darkening in mammals, and a method and composition thereof.
黑色素是天然色素,可能存在於皮膚、眼睛、頭髮、羽毛以及鱗片中,這些地方都是黑色素負責著色。Melanin is a natural pigment that may be found in the skin, eyes, hair, feathers and scales, where it is responsible for coloring.
黑色素的特徵為不規則的聚合物結構,且黑色素有兩大類,包含呈現棕黑色的真黑色素(eumelanin),以及呈現紅黃色的褐黑素(pheomelanin),根據這兩種色素的相對含量而決定髮色。Melanin is characterized by an irregular polymer structure. There are two major types of melanin, including eumelanin, which is brown-black, and pheomelanin, which is reddish-yellow. Hair color is determined by the relative content of these two pigments.
因為黑色素為一種較小成分分子的聚集體,所以黑色素聚集體/聚合的程度及分佈也會影響髮色。Because melanin is an aggregate of smaller component molecules, the degree and distribution of melanin aggregation/polymerization will also affect hair color.
在本發明中意外地發現一種與黑色素有效地相互作用的胜肽,進而刺激黑色素的聚合,其中該胜肽含有一7個胺基酸的模體(CRRWQWR)(SEQ ID NO: 1)。In the present invention, a peptide that effectively interacts with melanin and stimulates the polymerization of melanin is unexpectedly found, wherein the peptide contains a 7-amino acid motif (CRRWQWR) (SEQ ID NO: 1).
發現一種具有這種模體的胜肽能夠刺激黑色素聚合。於一些具體實施例中,本發明之用於刺激黑色素聚合的胜肽係選自由SEQ ID NOs: 4-14所組成之群組。It is found that a peptide having such a motif can stimulate melanin polymerization. In some embodiments, the peptide for stimulating melanin polymerization of the present invention is selected from the group consisting of SEQ ID NOs: 4-14.
因此,於一方面,本發明提供一種用於增加黑色素聚合之單離的胜肽。該單離的胜肽含有一如SEQ ID NO: 1所示之7個胺基酸的模體。於一些具體實施例中,該用於增加黑色素聚合的單離的胜肽係選自由SEQ ID NOs: 4-14所組成之群組。Therefore, in one aspect, the present invention provides an isolated peptide for increasing melanin polymerization. The isolated peptide contains a 7-amino acid motif as shown in SEQ ID NO: 1. In some specific embodiments, the isolated peptide for increasing melanin polymerization is selected from the group consisting of SEQ ID NOs: 4-14.
於另一方面,本發明提供一種用於在一哺乳動物個體中使髮色變黑之單離的胜肽。該單離的胜肽含有一如SEQ ID NO: 1所示之7個胺基酸的模體。於一些具體實施例中,該用於使髮色變黑之單離的胜肽係選自由SEQ ID NOs: 4-14所組成之群組。In another aspect, the present invention provides an isolated peptide for darkening hair color in a mammalian individual. The isolated peptide contains a 7-amino acid motif as shown in SEQ ID NO: 1. In some specific embodiments, the isolated peptide for darkening hair color is selected from the group consisting of SEQ ID NOs: 4-14.
於另一方面,本發明提供一種用於在一哺乳動物個體中使髮色變黑之組合物。該組合物包含一有效量的單離的胜肽,該單離的胜肽包含一如SEQ ID NO: 1所示之7個胺基酸的模體。根據本發明的某些具體實施例,該組合物可進一步包含一可接受的載體,並可被配製為一局部製劑。於一些具體實施例中,該單離的胜肽係選自由SEQ ID NOs: 4-14及其組合所組成之群組。In another aspect, the present invention provides a composition for darkening hair color in a mammalian subject. The composition comprises an effective amount of an isolated peptide, wherein the isolated peptide comprises a motif of 7 amino acids as shown in SEQ ID NO: 1. According to certain embodiments of the present invention, the composition may further comprise an acceptable carrier and may be formulated as a topical preparation. In some embodiments, the isolated peptide is selected from the group consisting of SEQ ID NOs: 4-14 and combinations thereof.
根據本發明,該局部製劑可包含一軟膏、一氣霧劑、一乳液、一乳霜、一凝膠、一滴劑、一噴霧劑、一液體、一貼劑、一洗髮精或一潤髮乳。於一較佳具體實施例中,將該組合物配製為一洗髮精或一潤髮乳。According to the present invention, the topical preparation may include an ointment, an aerosol, a lotion, a cream, a gel, a dropper, a spray, a liquid, a patch, a shampoo or a conditioner. In a preferred embodiment, the composition is formulated as a shampoo or a conditioner.
於另一方面,本發明提供一種在一有需要的個體中使髮色變黑之方法,該方法包含以一有效刺激該個體中黑色素聚合的量對該個體施用本發明之組合物。於本發明之較佳具體實施例中,該方法用於使該哺乳動物個體,較佳為一人類個體的髮色變黑。於本發明之較佳具體實施例中,將該組合物局部施用於該個體。In another aspect, the present invention provides a method for darkening hair color in a subject in need thereof, the method comprising administering to the subject a composition of the present invention in an amount effective to stimulate polymerization of melanin in the subject. In a preferred embodiment of the present invention, the method is used to darken the hair color of the mammalian subject, preferably a human subject. In a preferred embodiment of the present invention, the composition is topically administered to the subject.
應當理解的是,以上之一般描述與以下之詳細描述皆僅為示例性與說明性的,並不限制本發明。It should be understood that the above general description and the following detailed description are merely exemplary and illustrative and do not limit the present invention.
除非本文另有定義,否則本文所使用之科學及技術術語具有本領域普通技術人員通常理解之含義。Unless otherwise defined herein, scientific and technical terms used herein have the meanings commonly understood by one of ordinary skill in the art.
如本文所用,單數形式的「一」、「一個」以及「該」包括複數指示物,除非上下文另外明確指出。因此,例如,提及「一樣品」包括本領域技術人員已知的多個這樣的樣品及其等同物。As used herein, the singular forms "a", "an", and "the" include plural referents unless the context clearly dictates otherwise. Thus, for example, reference to "a sample" includes a plurality of such samples and equivalents thereof known to those skilled in the art.
如本文所用,「髮色變黑」或「使頭髮顏色變黑」等詞係指使頭髮的外觀變黑,包括,但不限於,使自然髮色變黑或使由於老化(如,灰髮或白髮)或外部侵害(如,過度暴露於陽光或氯氣中)而掉色的頭髮恢復原狀。As used herein, the terms "darkening" or "darkening hair color" refer to darkening the appearance of hair, including, but not limited to, darkening natural hair color or restoring hair that has lost color due to aging (e.g., gray or white hair) or external insults (e.g., excessive exposure to sunlight or chlorine).
「胜肽」乙詞在本文中以其常規含義使用,即其中單體為胺基酸且透過醯胺鍵連接在一起的聚合物,或稱為多胜肽。當胺基酸為α-胺基酸時,可使用L-光學異構體或D-光學異構體。另外,也意指包括非天然胺基酸,例如β-丙胺酸、苯甘胺酸以及高精胺酸。本文中使用胺基酸的標準縮寫。The term "peptide" is used herein in its conventional sense, i.e., a polymer in which the monomers are amino acids linked together by amide bonds, or a polypeptide. When the amino acid is an α-amino acid, either the L-optical isomer or the D-optical isomer may be used. In addition, it is also intended to include unnatural amino acids, such as β-alanine, phenylglycine, and homoarginine. Standard abbreviations for amino acids are used herein.
如本文所用,「用於刺激黑色素聚合的胜肽」或「用於使髮色變黑的胜肽」等詞係指長度為7個或更多個胺基酸殘基的具有實質性黑色素聚合活性的胜肽。較佳地,在刺激黑色素聚合的胜肽中包括至多約50個胺基酸殘基或40個,或30個,或25個,或20個,或15個,或10個,或6個胺基酸的胜肽。As used herein, the term "peptide for stimulating melanin polymerization" or "peptide for darkening hair color" refers to a peptide having a length of 7 or more amino acid residues and having substantial melanin polymerization activity. Preferably, the peptide stimulating melanin polymerization includes a peptide having up to about 50 amino acid residues or 40, or 30, or 25, or 20, or 15, or 10, or 6 amino acids.
如本文所用,「個體」乙詞可為被分類為哺乳動物的任何動物,包括人類。As used herein, the term "individual" may refer to any animal classified as a mammal, including humans.
如本文所用,「載體」乙詞係指通常用於藥物或化妝品組合物製劑的材料,其用於增強穩定性、無菌性及遞送性。當胜肽遞送系統配製為溶液或懸浮液時,該遞送系統在一可接受的載體中,較佳在一水性載體中。可使用多種水性載體,例如水、緩衝液、0.8%鹽水、0.3%甘胺酸、玻尿酸及其類似物。該組合物可包含近似生理條件所需的生理可接受的輔助物質,例如pH調節劑與緩衝劑、張力調節劑、潤濕劑及其類似物,例如,醋酸鈉、乳酸鈉、氯化鈉、氯化鉀、氯化鈣、脫水山梨糖醇單月桂酸酯、油酸三乙醇胺等。As used herein, the term "carrier" refers to a material commonly used in the formulation of pharmaceutical or cosmetic compositions to enhance stability, sterility and deliverability. When the peptide delivery system is formulated as a solution or suspension, the delivery system is in an acceptable carrier, preferably an aqueous carrier. A variety of aqueous carriers can be used, such as water, buffer, 0.8% saline, 0.3% glycine, hyaluronic acid and the like. The composition may contain physiologically acceptable auxiliary substances required to approximate physiological conditions, such as pH adjusters and buffers, tonicity adjusters, wetting agents and the like, for example, sodium acetate, sodium lactate, sodium chloride, potassium chloride, calcium chloride, sorbitan monolaurate, triethanolamine oleate, etc.
如本文所用,「局部」或「局部地」等詞在其常規意義上係指可在身體的任何部分之中或之上的位點,包括但不限於表皮,任何其他真皮或任何其他身體組織。局部給藥或施用係指將該胜肽與含有黑色素產生細胞的組織如皮膚或膜直接接觸。As used herein, the words "topical" or "topically" refer in their conventional sense to sites that may be in or on any part of the body, including but not limited to the epidermis, any other dermis or any other body tissue. Topical administration or application refers to direct contact of the peptide with tissues such as skin or membranes containing melanin-producing cells.
於一些具體實施例中,本發明提供一種單離的胜肽,其與黑色素有效相互作用,進而刺激黑色素的聚合,其中該胜肽包含一7個胺基酸的模體(CRRWQWR)(SEQ ID NO: 1)。較佳地,本發明之用於刺激黑色素聚合的胜肽係選自由SEQ ID NOs: 4-14及其組合所組成之群組。In some specific embodiments, the present invention provides an isolated peptide that effectively interacts with melanin to stimulate the polymerization of melanin, wherein the peptide comprises a 7-amino acid motif (CRRWQWR) (SEQ ID NO: 1). Preferably, the peptide for stimulating melanin polymerization of the present invention is selected from the group consisting of SEQ ID NOs: 4-14 and combinations thereof.
於一些具體實施例中,本發明提供一種用於在一哺乳動物個體中使髮色變黑之單離的胜肽。該單離的胜肽含有一如SEQ ID NO: 1所示之7個胺基酸的模體。於一些具體實施例中,該用於使髮色變黑之單離的胜肽係選自由SEQ ID NOs: 4-14及其組合所組成之群組。In some embodiments, the present invention provides an isolated peptide for darkening hair color in a mammalian individual. The isolated peptide contains a 7-amino acid motif as shown in SEQ ID NO: 1. In some embodiments, the isolated peptide for darkening hair color is selected from the group consisting of SEQ ID NOs: 4-14 and combinations thereof.
於一些具體實施例中,本發明提供一種用於在一哺乳動物個體中使髮色變黑之組合物。該組合物包含一有效量之單離的胜肽,該單離的胜肽包含一如SEQ ID NO: 1所示之7個胺基酸的模體。根據本發明的某些具體實施例,該組合物可進一步包含一可接受的載體,且可被配製為一局部製劑。於一些具體實施例中,該單離的胜肽係選自由SEQ ID NOs: 4-14及其組合所組成之群組。In some embodiments, the present invention provides a composition for darkening hair color in a mammalian subject. The composition comprises an effective amount of an isolated peptide, wherein the isolated peptide comprises a motif of 7 amino acids as shown in SEQ ID NO: 1. According to certain embodiments of the present invention, the composition may further comprise an acceptable carrier and may be formulated as a topical preparation. In some embodiments, the isolated peptide is selected from the group consisting of SEQ ID NOs: 4-14 and combinations thereof.
於一些具體實施例中,該局部製劑可包含一軟膏、一氣霧劑、一乳液、一乳霜、一凝膠、一滴劑、一噴霧劑、一液體、一貼劑、一洗髮精或一潤髮乳。於一較佳具體實施例中,將該組合物配製為一洗髮精或一潤髮乳。In some embodiments, the topical preparation may include an ointment, an aerosol, a lotion, a cream, a gel, a dropper, a spray, a liquid, a patch, a shampoo or a conditioner. In a preferred embodiment, the composition is formulated as a shampoo or a conditioner.
於一些具體實施例中,本發明提供一種在一有此需要的個體中使髮色變黑之方法,該方法包含以一有效刺激該個體中黑色素聚合的量對該個體施用本發明之組合物。於本發明之較佳具體實施例中,該方法用於使該哺乳動物個體,例如一人類個體的髮色變黑。於本發明之較佳具體實施例中,將該組合物局部施用於該個體。In some embodiments, the present invention provides a method of darkening hair color in a subject in need thereof, the method comprising administering to the subject a composition of the present invention in an amount effective to stimulate polymerization of melanin in the subject. In preferred embodiments of the present invention, the method is used to darken hair color in the mammalian subject, such as a human subject. In preferred embodiments of the present invention, the composition is topically administered to the subject.
本發明提供該含有一如SEQ ID NO: 1所示之7個胺基酸模體之單離的胜肽作為一用於各種用途的活性成分之用途。於一較佳的具體實施例中,將本發明之單離的胜肽與一可接受的載體組合以形成可被放置於皮膚上的一局部製劑。局部製劑可包含一軟膏、乳液、糊劑、乳霜、凝膠、滴劑、栓劑、噴霧劑、液體、洗髮精、潤髮乳、粉劑,以及穿皮貼劑。可根據需要使用增稠劑、稀釋劑、乳化劑、分散助劑,或黏合劑。較佳地,該載體之一功能為增強本發明之胜肽的皮膚滲透,並應能在體內條件下將該胜肽遞送至黑色素細胞。合適的載體為本領域普通技術人員所習知的,包括但不限於水、二甲亞碸、乙醇、脂質體、液體凡士林、凡士林二甲基甲醯胺、2-吡咯烷酮、油酸,以及Azone®品牌的滲透增強劑。The present invention provides the use of the isolated peptide containing a 7 amino acid motif as shown in SEQ ID NO: 1 as an active ingredient for various purposes. In a preferred embodiment, the isolated peptide of the present invention is combined with an acceptable carrier to form a topical preparation that can be placed on the skin. The topical preparation may include an ointment, lotion, paste, cream, gel, drop, suppository, spray, liquid, shampoo, conditioner, powder, and transdermal patch. Thickeners, diluents, emulsifiers, dispersing aids, or adhesives may be used as needed. Preferably, one function of the carrier is to enhance the skin penetration of the peptide of the present invention and should be able to deliver the peptide to melanocytes under in vivo conditions. Suitable carriers are known to those of ordinary skill in the art, including but not limited to water, dimethyl sulfoxide, ethanol, liposomes, liquid petrolatum, petrolatum dimethylformamide, 2-pyrrolidone, oleic acid, and Azone® brand penetration enhancers.
透過以下實施例進一步說明本發明,提供這些實施例係為說明而非限制。The present invention is further described by the following examples, which are provided for illustration and not limitation.
實施例Embodiment
1.1. 樣品製備Sample preparation
所有胜肽(表1)皆由基龍米克斯生物科技股份有限公司(Genomics Bioscience & Technology Co. Ltd.,台灣,台北)合成,並透過高效液相色層分析(high performance liquid chromatography,HPLC)與質譜儀確定這些胜肽的純度與組成。透過將10 mg凍乾的胜肽粉溶解在1 ml的雙去離子水(ddH2
O)中以製備胜肽原液,然後於-20o
C下保存。黑色素購自Sigma-Aldrich公司(美國,密蘇里州,聖路易斯市)。
表1. 合成胜肽庫
2.2. 黑色素之聚合作用Melanin polymerization
將0.025 mg/ml黑色素以50 μM胜肽處理24小時,然後以10,000g離心5分鐘。將上清液從試管中去除,僅留下黑色素沉澱物。於1 M NaOH中煮沸1小時後,定量黑色素的聚合作用,並於400 nm處以分光光度計測量吸光度。0.025 mg/ml melanin was treated with 50 μM peptide for 24 hours and then centrifuged at 10,000g for 5 minutes. The supernatant was removed from the tube, leaving only the melanin precipitate. After boiling in 1 M NaOH for 1 hour, the polymerization of melanin was quantified and the absorbance was measured at 400 nm by spectrophotometer.
結果result
如表1所示,以含有CRRWQWR (SEQ ID NO: 1)模體的50 μM胜肽處理的黑色素顯現出明顯的黑色素聚合。然而,SEQ ID NOs: 2、3及15未顯現出對黑色素聚合之作用(圖1與圖2)。As shown in Table 1, melanin treated with 50 μM peptide containing the CRRWQWR (SEQ ID NO: 1) motif showed obvious melanin polymerization. However, SEQ ID NOs: 2, 3, and 15 showed no effect on melanin polymerization (Figures 1 and 2).
本領域技術人員將理解,可在不脫離本發明之廣泛發明構思的情況下對上述具體實施例進行改變。因此,應當理解的是,本發明不限於所公開之特定具體實施例,而是目的在於涵蓋由所附請求項所限定之本發明的精神及範圍內的修改。Those skilled in the art will appreciate that changes may be made to the above specific embodiments without departing from the broad inventive concept of the present invention. Therefore, it should be understood that the present invention is not limited to the specific specific embodiments disclosed, but is intended to cover modifications within the spirit and scope of the present invention as defined by the appended claims.
無without
當結合附圖閱讀時,將更佳地理解上述發明內容與以下對本發明之詳細描述。為了說明本發明,於附圖中顯示目前較佳的具體實施例。When read in conjunction with the accompanying drawings, the above invention content and the following detailed description of the invention will be better understood. In order to illustrate the present invention, the currently preferred specific embodiments are shown in the accompanying drawings.
於圖式中:In the diagram:
圖1所示為於96孔盤中以50 μM胜肽處理0.025 mg/ml黑色素24小時,然後於一光學顯微鏡下攝影之結果。Figure 1 shows the results of treating 0.025 mg/ml melanin with 50 μM peptide for 24 hours in a 96-well plate and then photographing it under an optical microscope.
圖2所示為黑色素之聚合。以50 μM胜肽處理0.025 mg/ml黑色素24小時。數據表示為來自三個獨立實驗的平均值 ± SD。 ***p>0.001。Figure 2 shows the polymerization of melanin. 0.025 mg/ml melanin was treated with 50 μM peptide for 24 hours. Data are presented as mean ± SD from three independent experiments. ***p>0.001.
無without
<110> 肌活麗學創研所股份有限公司 <110> Muscle Vitality Research Institute Co., Ltd.
<120> 用於黑色素聚合及髮色變黑的胜肽、方法及組合物 <120> Peptides, methods and compositions for melanin polymerization and hair darkening
<130> 0766/REN0003TW <130> 0766/REN0003TW
<160> 15 <160> 15
<170> PatentIn version 3.5 <170> PatentIn version 3.5
<210> 1 <210> 1
<211> 7 <211> 7
<212> PRT <212> PRT
<213> Artificial Sequence <213> Artificial Sequence
<220> <220>
<223> Peptide <223> Peptide
<400> 1 <400> 1
<210> 2 <210> 2
<211> 13 <211> 13
<212> PRT <212> PRT
<213> Artificial Sequence <213> Artificial Sequence
<220> <220>
<223> Peptide <223> Peptide
<400> 2 <400> 2
<210> 3 <210> 3
<211> 13 <211> 13
<212> PRT <212> PRT
<213> Artificial Sequence <213> Artificial Sequence
<220> <220>
<223> Peptide <223> Peptide
<400> 3 <400> 3
<210> 4 <210> 4
<211> 8 <211> 8
<212> PRT <212> PRT
<213> Artificial Sequence <213> Artificial Sequence
<220> <220>
<223> Peptide <223> Peptide
<400> 4 <400> 4
<210> 5 <210> 5
<211> 9 <211> 9
<212> PRT <212> PRT
<213> Artificial Sequence <213> Artificial Sequence
<220> <220>
<223> Peptide <223> Peptide
<400> 5 <400> 5
<210> 6 <210> 6
<211> 11 <211> 11
<212> PRT <212> PRT
<213> Artificial Sequence <213> Artificial Sequence
<220> <220>
<223> Peptide <223> Peptide
<400> 6 <400> 6
<210> 7 <210> 7
<211> 13 <211> 13
<212> PRT <212> PRT
<213> Artificial Sequence <213> Artificial Sequence
<220> <220>
<223> Peptide <223> Peptide
<400> 7 <400> 7
<210> 8 <210> 8
<211> 18 <211> 18
<212> PRT <212> PRT
<213> Artificial Sequence <213> Artificial Sequence
<220> <220>
<223> Peptide <223> Peptide
<400> 8 <400> 8
<210> 9 <210> 9
<211> 25 <211> 25
<212> PRT <212> PRT
<213> Artificial Sequence <213> Artificial Sequence
<220> <220>
<223> Peptide <223> Peptide
<400> 9 <400> 9
<210> 10 <210> 10
<211> 11 <211> 11
<212> PRT <212> PRT
<213> Artificial Sequence <213> Artificial Sequence
<220> <220>
<223> Peptide <223> Peptide
<400> 10 <400> 10
<210> 11 <210> 11
<211> 12 <211> 12
<212> PRT <212> PRT
<213> Artificial Sequence <213> Artificial Sequence
<220> <220>
<223> Peptide <223> Peptide
<400> 11 <400> 11
<210> 12 <210> 12
<211> 7 <211> 7
<212> PRT <212> PRT
<213> Artificial Sequence <213> Artificial Sequence
<220> <220>
<223> Peptide <223> Peptide
<400> 12 <400> 12
<210> 13 <210> 13
<211> 11 <211> 11
<212> PRT <212> PRT
<213> Artificial Sequence <213> Artificial Sequence
<220> <220>
<223> Peptide <223> Peptide
<400> 13 <400> 13
<210> 14 <210> 14
<211> 10 <211> 10
<212> PRT <212> PRT
<213> Artificial Sequence <213> Artificial Sequence
<220> <220>
<223> Peptide <223> Peptide
<400> 14 <400> 14
<210> 15 <210> 15
<211> 10 <211> 10
<212> PRT <212> PRT
<213> Artificial Sequence <213> Artificial Sequence
<220> <220>
<223> Peptide <223> Peptide
<400> 15 <400> 15
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW109101268A TWI859182B (en) | 2020-01-14 | 2020-01-14 | Peptide, method and composition for melanin polymerization and hair darkening |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW109101268A TWI859182B (en) | 2020-01-14 | 2020-01-14 | Peptide, method and composition for melanin polymerization and hair darkening |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW202126282A TW202126282A (en) | 2021-07-16 |
| TWI859182B true TWI859182B (en) | 2024-10-21 |
Family
ID=77908628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW109101268A TWI859182B (en) | 2020-01-14 | 2020-01-14 | Peptide, method and composition for melanin polymerization and hair darkening |
Country Status (1)
| Country | Link |
|---|---|
| TW (1) | TWI859182B (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103382217A (en) * | 2012-12-11 | 2013-11-06 | 任发政 | Cell-penetrating peptide and pharmaceutical composition and preparation method and application thereof |
| TW201730204A (en) * | 2016-02-23 | 2017-09-01 | 肌活麗學創研所股份有限公司 | Peptide, method and composition for stimulating melanogenesis |
-
2020
- 2020-01-14 TW TW109101268A patent/TWI859182B/en active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103382217A (en) * | 2012-12-11 | 2013-11-06 | 任发政 | Cell-penetrating peptide and pharmaceutical composition and preparation method and application thereof |
| TW201730204A (en) * | 2016-02-23 | 2017-09-01 | 肌活麗學創研所股份有限公司 | Peptide, method and composition for stimulating melanogenesis |
Non-Patent Citations (2)
| Title |
|---|
| 期刊 Huang, Hsiu-Chin, Hsuan Lin, and Min-Chuan Huang. "The lactoferricin B-derived peptide, LfB 17-34, induces melanogenesis in B16F10 cells." International Journal of Molecular Medicine 39.3 (2017): 595-602. |
| 期刊 Huertas, Nataly de Jesus, et al. "Antimicrobial activity of truncated and polyvalent peptides derived from the FKCRRWQWRMKKGLA sequence against Escherichia coli ATCC 25922 and staphylococcus aureus ATCC 25923." Molecules 22.6 (2017): 987.;期刊 Huang, Hsiu-Chin, Hsuan Lin, and Min-Chuan Huang. "The lactoferricin B-derived peptide, LfB 17-34, induces melanogenesis in B16F10 cells." International Journal of Molecular Medicine 39.3 (2017): 595-602. * |
Also Published As
| Publication number | Publication date |
|---|---|
| TW202126282A (en) | 2021-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2596597A1 (en) | Method for stimulation collagen synthesis and/or kgf expression | |
| CN105362088A (en) | A kind of polypeptide composition for whitening, lightening skin and lightening spots | |
| CN109134609B (en) | Antiaging peptides, compositions and methods of use | |
| TWI859182B (en) | Peptide, method and composition for melanin polymerization and hair darkening | |
| EA038745B1 (en) | Conjugate of minoxidil and peptide | |
| CN107098962B (en) | Peptides, methods and compositions for stimulating melanin production | |
| US11236138B2 (en) | Peptide, method and composition for melanin polymerization and hair darkening | |
| EP2523967B1 (en) | Novel anti-ageing peptides modulating survivin and compositions including same | |
| TW202506705A (en) | Peptide, method and composition for melanin polymerization and hair darkening | |
| US8080524B2 (en) | Agent for slowing hair loss and/or stimulating hair growth | |
| TWI634123B (en) | Peptide, method and composition for stimulating melanogenesis | |
| CA2423190C (en) | Angiogenic agents and their uses | |
| CN110467650B (en) | Peptide for promoting melanogenesis and method thereof | |
| TWI614022B (en) | Peptide, method and composition for decreasing melanin content | |
| US9655834B1 (en) | Peptide, method and composition for inhibiting melanogenesis | |
| US10258557B2 (en) | Peptide for stimulating melanogenesis | |
| TWI873241B (en) | Peptides and compositions for use in cosmetics and medicine | |
| TWI627186B (en) | Peptide for stimulating melanogenesis | |
| TWI821502B (en) | Peptide, composition and method for anti-hair graying | |
| KR20210012350A (en) | Artificial layer cream composition having superior moisture retention and skin penetration effect by nanoliposome treatment method | |
| JP6892903B2 (en) | Peptides that promote the production of melanin and methods thereof | |
| US11154482B2 (en) | Peptide, composition and method for anti-hair graying | |
| HK40073324A (en) | Peptides and compositions for use in cosmetics and medicine | |
| TW201904984A (en) | Anti-aging peptide, its composition and method of using the same |